Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

Phase 2
2(50.0%)
N/A
1(25.0%)
Phase 4
1(25.0%)
4Total
Phase 2(2)
N/A(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05977712Recruiting

Circadian Rhythm and Other Factors in Memory Clinic Patients

Role: collaborator

NCT04681417Phase 2Recruiting

Ocular Conservative Treatment for Retinoblastoma : Efficacy of the New Management Strategies and Visual Outcome

Role: collaborator

NCT02866136Phase 2Active Not Recruiting

Conservative Treatments of Retinoblastoma

Role: collaborator

NCT05034835Not ApplicableRecruiting

Impact of Compression Garments on Pain in Patients With Complex Regional Pain Syndrome of the Upper Limbs.

Role: collaborator

NCT01765257Phase 4Unknown

Evaluation of the Efficacy of Rasagiline in Apathy in Drug-naïve Patients With Parkinson's Disease by a Multi-center Study

Role: collaborator

All 5 trials loaded